Chemo-Radiotherapy Boost Treatment Guided by Perfusion MRI on Hypoxic Zones in Head and Neck Cancer

NCT06880289 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

91

Enrollment

OTHER

Sponsor class

Conditions

Squamous Cell Tumors of the Head and Neck

Interventions

DRUG: Cisplatin IV on days 1, 22, 43, at a dose of 100 mg/m2

Sponsor

Regina Elena Cancer Institute